JNJ - Johnson & Johnson
NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 346.6B |
| Enterprise value 3 | 361.75B |
| Trailing P/E | 21.81 |
| Forward P/E 1 | 14.40 |
| PEG ratio (5-yr expected) 1 | 2.36 |
| Price/sales (ttm) | 4.26 |
| Price/book (mrq) | 5.71 |
| Enterprise value/revenue 3 | 4.45 |
| Enterprise value/EBITDA 6 | 12.92 |
Trading information
Stock price history
| Beta (3Y monthly) | 0.73 |
| 52-week change 3 | -3.65% |
| S&P500 52-week change 3 | 6.81% |
| 52-week high 3 | 148.99 |
| 52-week low 3 | 121.00 |
| 50-day moving average 3 | 130.00 |
| 200-day moving average 3 | 134.90 |
Share statistics
| Avg vol (3-month) 3 | 7.36M |
| Avg vol (10-day) 3 | 6.8M |
| Shares outstanding 5 | 2.64B |
| Float | 2.64B |
| % held by insiders 1 | 0.07% |
| % held by institutions 1 | 69.23% |
| Shares short (30 Sep 2019) 4 | 16.66M |
| Short ratio (30 Sep 2019) 4 | 2.66 |
| Short % of float (30 Sep 2019) 4 | 0.63% |
| Short % of shares outstanding (30 Sep 2019) 4 | 0.63% |
| Shares short (prior month 30 Aug 2019) 4 | 14.28M |
Dividends & splits
| Forward annual dividend rate 4 | 3.8 |
| Forward annual dividend yield 4 | 2.94% |
| Trailing annual dividend rate 3 | 3.65 |
| Trailing annual dividend yield 3 | 2.83% |
| 5-year average dividend yield 4 | 2.67 |
| Payout ratio 4 | 60.53% |
| Dividend date 3 | 10 Sep 2019 |
| Ex-dividend date 4 | 26 Aug 2019 |
| Last split factor (new per old) 2 | 1/2 |
| Last split date 3 | 13 Jun 2001 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2018 |
| Most-recent quarter (mrq) | 30 Jun 2019 |
Profitability
| Profit margin | 20.08% |
| Operating margin (ttm) | 25.90% |
Management effectiveness
| Return on assets (ttm) | 8.48% |
| Return on equity (ttm) | 26.41% |
Income statement
| Revenue (ttm) | 81.32B |
| Revenue per share (ttm) | 30.47 |
| Quarterly revenue growth (yoy) | -1.30% |
| Gross profit (ttm) | 54.59B |
| EBITDA | 28B |
| Net income avi to common (ttm) | 16.33B |
| Diluted EPS (ttm) | 6.02 |
| Quarterly earnings growth (yoy) | 41.80% |
Balance sheet
| Total cash (mrq) | 15.28B |
| Total cash per share (mrq) | 5.79 |
| Total debt (mrq) | 30.43B |
| Total debt/equity (mrq) | 50.06 |
| Current ratio (mrq) | 1.33 |
| Book value per share (mrq) | 23.01 |
Cash flow statement
| Operating cash flow (ttm) | 22.01B |
| Levered free cash flow (ttm) | 22.35B |